Literature DB >> 9323207

Structure-based analysis of catalysis and substrate definition in the HIT protein family.

C D Lima1, M G Klein, W A Hendrickson.   

Abstract

The histidine triad (HIT) protein family is among the most ubiquitous and highly conserved in nature, but a biological activity has not yet been identified for any member of the HIT family. Fragile histidine triad protein (FHIT) and protein kinase C interacting protein (PKCI) were used in a structure-based approach to elucidate characteristics of in vivo ligands and reactions. Crystallographic structures of apo, substrate analog, pentacovalent transition-state analog, and product states of both enzymes reveal a catalytic mechanism and define substrate characteristics required for catalysis, thus unifying the HIT family as nucleotidyl hydrolases, transferases, or both. The approach described here may be useful in identifying structure-function relations between protein families identified through genomics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323207     DOI: 10.1126/science.278.5336.286

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  72 in total

1.  A test case for structure-based functional assignment: the 1.2 A crystal structure of the yjgF gene product from Escherichia coli.

Authors:  K Volz
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases.

Authors:  Charles Brenner
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

3.  Annotation in three dimensions. PINTS: Patterns in Non-homologous Tertiary Structures.

Authors:  Alexander Stark; Robert B Russell
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Functional analysis of mRNA scavenger decapping enzymes.

Authors:  Shin-Wu Liu; Xinfu Jiao; Hudan Liu; Meigang Gu; Christopher D Lima; Megerditch Kiledjian
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

5.  BODIL: a molecular modeling environment for structure-function analysis and drug design.

Authors:  Jukka V Lehtonen; Dan-Johan Still; Ville-V Rantanen; Jan Ekholm; Dag Björklund; Zuhair Iftikhar; Mikko Huhtala; Susanna Repo; Antti Jussila; Jussi Jaakkola; Olli Pentikäinen; Tommi Nyrönen; Tiina Salminen; Mats Gyllenberg; Mark S Johnson
Journal:  J Comput Aided Mol Des       Date:  2004-06       Impact factor: 3.686

6.  Ternary borate-nucleoside complex stabilization by ribonuclease A demonstrates phosphate mimicry.

Authors:  Scott A Gabel; Robert E London
Journal:  J Biol Inorg Chem       Date:  2007-10-24       Impact factor: 3.358

7.  Adenosine monophosphoramidase activity of Hint and Hnt1 supports function of Kin28, Ccl1, and Tfb3.

Authors:  Pawel Bieganowski; Preston N Garrison; Santosh C Hodawadekar; Gerard Faye; Larry D Barnes; Charles Brenner
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

8.  Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine.

Authors:  Bao-Zhu Yuan; Amy M Jefferson; Nicholas C Popescu; Steven H Reynolds
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

9.  Design, Synthesis, and Characterization of Sulfamide and Sulfamate Nucleotidomimetic Inhibitors of hHint1.

Authors:  Rachit Shah; Alexander Strom; Andrew Zhou; Kimberly M Maize; Barry C Finzel; Carston R Wagner
Journal:  ACS Med Chem Lett       Date:  2016-06-15       Impact factor: 4.345

10.  Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.

Authors:  Francesco Trapasso; Agnieszka Krakowiak; Rossano Cesari; Jeffrey Arkles; Sai Yendamuri; Hideshi Ishii; Andrea Vecchione; Tamotsu Kuroki; Pawel Bieganowski; Helen C Pace; Kay Huebner; Carlo M Croce; Charles Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.